CalciMedica (CALC) News Today $2.76 -0.01 (-0.36%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period LUCID CAPITAL MARKETS Initiates Coverage of CalciMedica (CALC) with Buy RecommendationDecember 18 at 3:12 AM | msn.comInsider Buying: CalciMedica, Inc. (NASDAQ:CALC) Director Buys 4,800 Shares of StockDecember 7, 2024 | insidertrades.comComprehensive 2024 Insights into the Acute Pancreatitis Pipeline Treatment Landscape Featuring CalciMedica, SCM Lifescience, and Lamassu PharmaNovember 27, 2024 | finance.yahoo.comCalciMedica to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 21, 2024 | prnewswire.comCalciMedica Announces Presentations at Upcoming Medical MeetingsNovember 20, 2024 | prnewswire.comInsiders Bet Big on These Small Cap StocksNovember 14, 2024 | insidertrades.comCalciMedica, Inc.: CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesNovember 14, 2024 | finanznachrichten.deCalciMedica’s Financial Strength and Clinical Advancements Lead to Buy RatingNovember 14, 2024 | markets.businessinsider.comCalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesNovember 13, 2024 | prnewswire.comCalciMedica Appoints Stephen Bardin as New CFONovember 9, 2024 | markets.businessinsider.comCalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial OfficerNovember 7, 2024 | prnewswire.comSanderling Venture Partners Vi Buys 86,867 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockNovember 6, 2024 | insidertrades.comCalciMedica’s Auxora Shows Promise in Acute Pancreatitis: Analyst Recommends BuyNovember 5, 2024 | markets.businessinsider.comCalciMedica price target lowered to $16 from $20 at H.C. WainwrightNovember 5, 2024 | markets.businessinsider.comA. Rachel Leheny Buys 20,000 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockNovember 2, 2024 | insidertrades.comCalciMedica (NASDAQ:CALC) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comCalciMedica announces common stock offering, no amount givenNovember 1, 2024 | markets.businessinsider.comCalciMedica Announces Pricing of Public Offering of Common StockOctober 30, 2024 | prnewswire.comCalciMedica Announces Proposed Public Offering of Common StockOctober 30, 2024 | prnewswire.comCalciMedica, Inc. (NASDAQ:CALC) Short Interest Down 9.3% in OctoberCalciMedica, Inc. (NASDAQ:CALC - Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 34,200 shares, a decrease of 9.3% from the September 30th total of 37,700 shares. Based on an average daily trading volume, of 35,500 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.8% of the company's stock are short sold.October 30, 2024 | marketbeat.comCalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific MeetingOctober 30, 2024 | prnewswire.comCalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)October 28, 2024 | prnewswire.comCalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific MeetingOctober 16, 2024 | prnewswire.comCalciMedica (NASDAQ:CALC) Trading Down 2%CalciMedica (NASDAQ:CALC) Stock Price Down 2%September 24, 2024 | marketbeat.comCalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | prnewswire.comDirector Robert Wilson Acquires 54,000 Shares of CalciMedica Inc (CALC)August 27, 2024 | finance.yahoo.comInsider Buying: CalciMedica, Inc. (NASDAQ:CALC) Insider Purchases 5,000 Shares of StockAugust 27, 2024 | insidertrades.comEric W. Roberts Purchases 5,000 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockAugust 23, 2024 | insidertrades.comCalciMedica, Inc.: CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesAugust 18, 2024 | finanznachrichten.deOppenheimer maintains target on CalciMedica stock, sees growth potentialAugust 16, 2024 | uk.investing.comOppenheimer Reaffirms Their Buy Rating on Xeris Pharmaceuticals (XERS)August 13, 2024 | markets.businessinsider.comCalciMedica (NASDAQ:CALC) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $20.00 price target on shares of CalciMedica in a research note on Tuesday.August 13, 2024 | marketbeat.comCalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesAugust 12, 2024 | prnewswire.comCalciMedica, Inc. (CALC)July 20, 2024 | finance.yahoo.comCalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)July 9, 2024 | prnewswire.comCalciMedica Announces Presentations at Two Upcoming Healthcare Investment ConferencesJuly 8, 2024 | prnewswire.comInsider Buying: CalciMedica, Inc. (NASDAQ:CALC) Director Purchases 8,443 Shares of StockJuly 2, 2024 | insidertrades.comCalciMedica Set to Join Russell Microcap® IndexJuly 1, 2024 | prnewswire.comCalciMedica, Inc. (NASDAQ:CALC) Insider Buys $16,100.00 in StockJune 29, 2024 | insidertrades.comCalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)June 27, 2024 | prnewswire.comCalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)June 26, 2024 | prnewswire.comShort Interest in CalciMedica, Inc. (NASDAQ:CALC) Drops By 21.9%CalciMedica, Inc. (NASDAQ:CALC - Get Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 23,600 shares, a decrease of 21.9% from the May 15th total of 30,200 shares. Currently, 0.5% of the shares of the stock are sold short. Based on an average trading volume of 20,200 shares, the days-to-cover ratio is currently 1.2 days.June 15, 2024 | marketbeat.comShort Interest in CalciMedica, Inc. (NASDAQ:CALC) Decreases By 30.6%CalciMedica, Inc. (NASDAQ:CALC - Get Free Report) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 30,200 shares, a decrease of 30.6% from the April 30th total of 43,500 shares. Based on an average daily volume of 20,100 shares, the days-to-cover ratio is presently 1.5 days. Currently, 0.6% of the shares of the company are sold short.June 1, 2024 | marketbeat.comCALC Stock Earnings: CalciMedica Beats EPS for Q1 2024May 28, 2024 | investorplace.comOppenheimer maintains Outperform on CalciMedica stockMay 22, 2024 | uk.investing.comAnalysts Offer Insights on Healthcare Companies: CalciMedica (CALC) and GE Healthcare Technologies Inc (GEHC)May 20, 2024 | markets.businessinsider.comFY2024 EPS Estimates for CalciMedica, Inc. (NASDAQ:CALC) Raised by HC WainwrightCalciMedica, Inc. (NASDAQ:CALC - Free Report) - Equities researchers at HC Wainwright increased their FY2024 earnings per share estimates for shares of CalciMedica in a report released on Tuesday, May 14th. HC Wainwright analyst J. Pantginis now expects that the company will earn ($1.86) per sharMay 17, 2024 | marketbeat.comQ2 2024 EPS Estimates for CalciMedica, Inc. Boosted by Analyst (NASDAQ:CALC)CalciMedica, Inc. (NASDAQ:CALC - Free Report) - Research analysts at HC Wainwright lifted their Q2 2024 earnings per share (EPS) estimates for CalciMedica in a report released on Tuesday, May 14th. HC Wainwright analyst J. Pantginis now forecasts that the company will earn ($0.42) per share for tMay 16, 2024 | marketbeat.comCalciMedica, Inc.: CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesMay 14, 2024 | finanznachrichten.deOptimistic Buy Rating for CalciMedica Backed by Strong Financials and Promising Clinical TrialsMay 14, 2024 | markets.businessinsider.com Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode. >> Register for the Workshop Now CALC Media Mentions By Week CALC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CALC News Sentiment▼0.000.61▲Average Medical News Sentiment CALC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CALC Articles This Week▼11▲CALC Articles Average Week Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Puma Biotechnology News Elutia News Instil Bio News Black Diamond Therapeutics News Galectin Therapeutics News Compugen News Telomir Pharmaceuticals News Monopar Therapeutics News Enanta Pharmaceuticals News Atossa Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CALC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredWhat most folks don’t know about oil (BIG missed opportunity)$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Go...ProsperityPub | SponsoredHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buyi...Insiders Exposed | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—wit...Darwin | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
